Your browser doesn't support javascript.
loading
Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
Rollie, Clare; Chevallereau, Anne; Watson, Bridget N J; Chyou, Te-Yuan; Fradet, Olivier; McLeod, Isobel; Fineran, Peter C; Brown, Chris M; Gandon, Sylvain; Westra, Edze R.
Afiliação
  • Rollie C; ESI, Biosciences, University of Exeter, Penryn, UK. C.Rollie@exeter.ac.uk.
  • Chevallereau A; ESI, Biosciences, University of Exeter, Penryn, UK. A.Chevallereau@exeter.ac.uk.
  • Watson BNJ; ESI, Biosciences, University of Exeter, Penryn, UK.
  • Chyou TY; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
  • Fradet O; ESI, Biosciences, University of Exeter, Penryn, UK.
  • McLeod I; ESI, Biosciences, University of Exeter, Penryn, UK.
  • Fineran PC; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Brown CM; Genetics Otago, University of Otago, Dunedin, New Zealand.
  • Gandon S; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
  • Westra ER; Genetics Otago, University of Otago, Dunedin, New Zealand.
Nature ; 579(7799): E10, 2020 03.
Article em En | MEDLINE | ID: mdl-32123354
ABSTRACT
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article